Skip to main content
PCVX $58.82 +0.50%
PCVX logo
PCVX · Vaxcyte, Inc.
Track PCVX — free
$58.82 +0.30 (+0.50%) Play latest call Q4 2025 earnings call transcript
Market Cap
$9.26B
Shares
158.30M
Volume · Nov 19 213.59K Avg daily vol (3M) 2.16M
All webcasts

Earnings call · FY2025 Q2

Vaxcyte, Inc. (PCVX) Q2 2025 Earnings Call

Concluded Aug 6, 2025
Aug 6, 2025
Period
FY2025 Q2
Runtime
—
Sources
2 artifacts
Diluted EPS -$1.22
Net income -$166.57M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 6, 2025.

Metric Guided
Capital and facility buildout expenditures (total cost)
buildout completed by early 2026
$300M – $350M
Full-screen source Call document